Fibrose pulmonaire idiopathique
Code/s CIM-10 : J84.1
Auteur : Article non édité
Dernière mise à jour : 30/11/-0001
A éditer.
Causes : A éditer
Traitements
Liste des traitements : 1ème ligne
- Aucun.e traitement renseigné.e pour cette maladie, pour l'instant.
Examens diagnostiques
- Aucun.e examen renseigné.e pour cette maladie, pour l'instant.
Scores, Listes utiles
- Aucun.e score renseigné.e pour cette maladie, pour l'instant.
Diagnostic différentiel
Références
-
Recos France 2022. Recommandations de pratique clinique : Recommandations pratiques pour le diagnostic et la prise en charge de la fibrose pulmonaire idiopathique – Actualisation 2021. Version courte. Revue des Maladies Respiratoires54 recommandations ont été formulées, .. portant sur des aspects multiples de la maladie : épidémiologie, modalités diagnostiques, critères de qualité et interprétation du scanner thoracique, indication et réalisation de la biopsie pulmonaire, bilan étiologique, modalités et indications de l’enquête familiale et de l’analyse génétique, évaluation du retentissement fonctionnel et du pronostic, indication et emploi des médicaments antifibrosants, transplantation pulmonaire
-
Recos International 2018. Recommandations de pratique clinique : Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit CareThe guideline panel updated the diagnostic criteria for IPF. Previously defined patterns of usual interstitial pneumonia (UIP) were refined to patterns of UIP, probable UIP, indeterminate for UIP, and alternate diagnosis. For patients with newly detected interstitial lung disease (ILD) who have a high-resolution computed tomography scan pattern of probable or indeterminate for UIP, or an alternative diagnosis, conditional recommendations were made for performing BAL and surgical lung biopsy; In contrast, fo
-
Recos Internationales IPF 2022. Recommandations de pratique clinique : Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med1) Update of idiopathic pulmonary fibrosis (IPF): A conditional recommendation was made to regard transbronchial lung cryobiopsy as an acceptable alternative ... No recommendation was made for or against genomic classifier testing. Conditional recommendations were made against antacid medication and antireflux surgery for the treatment of IPF. 2) Progressive pulmonary fibrosis: PPF was defined as at least two of three criteria (worsening symptoms, radiological progression, and physiological progression) occ
-
Recos USA ATS 2025. Recommandations de pratique clinique : Approach to the Evaluation and Management of Interstitial Lung Abnormalities: An Official American Thoracic Society Clinical Statement. Am J Respir Crit Care Medinterstitial lung abnormalities (ILAs) [are] defined as nondependent bilateral parenchymal abnormalities on computed tomography, including ground-glass opacities or reticulations, lung distortion, traction bronchiectasis, and/or honeycombing involving ≥5% of a lung zone. The updated definition removes the prior exclusion of high-risk populations. Interstitial lung disease (ILD) is distinguished from ILAs by symptoms (dyspnea/cough) .., abnormal or declining lung function, fibrotic (honeycombing and/or retic
-
Wijsenbeek 2020. Revue narrative : Spectrum of Fibrotic Lung Diseases. N Engl J MedThis review covers fibrotic pulmonary diseases. Although idiopathic pulmonary fibrosis is very common, the review focuses mainly on fibrotic diseases other than idiopathic pulmonary fibrosis. The biology, clinical presentation, and treatment of the more common disorders are discussed.